Back to results
US 2019/0160088 A1Published application
Uttroside B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma
AssigneeRajiv Gandhi Centre for Biotechnology, An Autonomous Institute Under the Department of Biotechnology. Government of India
InventorsRuby John Anto, Lekshmi Reghu Nath
Life of this patent
Estimating the term…
Abstract
The present invention includes Uttroside B compositions and method for the treatment of hepatocellular carcinoma. Chemotherapeutic options for liver cancer are limited and the prognosis of HCC patients remains dismal. Sorafenib, is the only drug currently available for the treatment of hepatocellular carcinoma.
Claims27
-16. (canceled)
A composition for the treatment of a liver disease, wherein the composition comprises:
- a pharmaceutically effective amount of Uttroside B disposed in a pharmaceutical carrier.
A method of treating a liver disease, comprising:
- identifying a subject on need of treatment for the liver disease;
- and providing the subject with a pharmaceutically effective amount of Uttroside B sufficient to treat the liver disease.
Dependencies are inferred from the claim text.